Phase 2 study for people with Heart Disease

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Atom Therapeutics Co., Ltd
Registry number NCT07303777
Started 23 April 2026 Today 16 October 2026 Estimated completion 1 January 2028

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
NovaTrails Newcastle NSW Not yet recruiting
University of the Sunshine Coast Clinical Trials Unit - Morayfield Morayfield QLD Not yet recruiting
Core Research Group Pty Ltd Brisbane Australia Not yet recruiting
UniSC Clinical Trials (Brisbane) Brisbane Australia Not yet recruiting
Cognivus Wahroonga Australia Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 75 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 200

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

Unless otherwise specified, subjects must meet all of the following criteria at screening:

* Diagnosed with coronary at herosclerosis, and coronary angiography.

* Male or female at 18-75 years of age (inclusive).

* Weight ≥40 kg.

* Currently using any oral lipid-lowering therapy.

* Able to understand and willing to sign an ICF and comply with study requirements.

* A woman or man of childbearing potential agreeing to use medically approved contraceptive methods from the screening until 3 months after the last study dose.

Exclusion Criteria:

Unless otherwise specified, subjects are excluded from the study if any of the following criteria is met:

* History of stroke within the past 6 months.

* Uncontrolled arrhythmia within 3 months prior to screening.

* Evidence of any active or suspected cancer within 3 years prior to the screening.

* Having undergone any major surgery within 3 months prior to the screening or planning to undergo any major surgery during the study.

* Presence or suspicion of ongoing of any serious infection.

* Human immunodeficiency virus (HIV) infection.

Dates on the record

Started 23 April 2026
Estimated completion 1 January 2028
Registry last updated 28 April 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 28 April 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.